AC
ASBPW

Antara Capital’s Aspire Biopharma Warrant ASBPW Stock Holding History

Antara Capital’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.43K Hold
207,693
– – 11.35% 2
2025
Q3 		$6.21K Buy
+207,693
New +$10.5K 1.27% 3

Other funds holding ASBPW

MTCM
Mint Tower Capital Management Amsterdam, Netherlands $871M AUM 8.61% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Antara Capital's ASBPW Position: Q4 2025 in Review

Antara Capital held its Aspire Biopharma Warrant (ASBPW) position steady in Q4 2025 at 207,693 shares worth $3.43K. The position accounts for 11.35% of the portfolio, ranked #2.

Antara Capital first reported a position in ASBPW in Q3 2025 and has held it in 2 quarters since. The position peaked at $6.21K in Q3 2025. 29 funds tracked by Wall St. Rank hold ASBPW as of Q4 2025.

  • Antara Capital held 207,693 shares of Aspire Biopharma Warrant worth $3.43K as of Q4 2025.
  • Antara Capital left its Aspire Biopharma Warrant share count unchanged in Q4 2025.
  • Aspire Biopharma Warrant made up 11.35% of Antara Capital's portfolio in Q4 2025, its #2 holding.
  • Antara Capital first reported a position in Aspire Biopharma Warrant in Q3 2025 and has held it in 2 quarters since.
  • Antara Capital's Aspire Biopharma Warrant position peaked at $6.21K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q4 2025.

Based on Antara Capital's 13F filing for Q4 2025, filed 17 Feb 2026.